Pluto Bioinformatics

GSE64771: Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Bulk RNA sequencing

We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions SOURCE: Qiang Hu (Qiang.Hu@RoswellPark.org) - Roswell Park Cancer Institute